All In Biotech

Drug Trial Radar · NCT05368285

A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria

A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-finding Study to Assess the Efficacy and Safety of CDX-0159 in Patients With Chronic Spontaneous Urticaria

Last checked: Nov 20, 2026Latest source record: Mar 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 208 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

208

Actual

Start

May 19, 2022

Primary completion

Sep 28, 2023

Study completion Dec 20, 2024

Sponsor

Lead sponsor
Celldex TherapeuticsIndustry
Sponsor type
Industry
First posted
May 10, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the clinical effect, the pharmacodynamics, the safety, and the pharmacokinetics of barzolvolimab (CDX-0159) in patients with Chronic Spontaneous Urticaria

Conditions

  • Chronic Spontaneous Urticaria

Interventions

  • barzolvolimabBiological

    Subcutaneous Administration

  • Matching PlaceboDrug

    Subcutaneous Administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change from baseline to Week 12 of UAS7 (Urticaria Activity Score)Time frame: From baseline to Day 85 (Week 12)

Locations

56 sites in 9 countries. Site status is shown where the registry gives one.

  • Clinical Research Center of Alabama dba Allervie Clinical Research

    Birmingham, Alabama

  • Medical Research of Arizona

    Scottsdale, Arizona

  • Little Rock Allergy & Asthma CRC

    Little Rock, Arkansas

  • Kern Research, Inc

    Bakersfield, California

  • Allergy & Asthma Consultants

    Redwood City, California

  • IMMUNOe Research Centers

    Centennial, Colorado

  • Treasure Valley Medical Research

    Boise, Idaho

  • Allergy & Asthma Specialists, PSC

    Owensboro, Kentucky

  • Institute for Asthma and Allergy

    Chevy Chase, Maryland

  • Chesapeake Clinical Research

    White Marsh, Maryland

  • Respiratory Medicine Research Institute of Michigan, PLC

    Ypsilanti, Michigan

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • Montefiore Medical Center/Subspeciality-Allergy and Immunology

    The Bronx, New York

  • "Diagnostic Consultative Center Pulmed" EOOD

    Plovdiv, Bulgaria

  • University Multiprofile Hospital for Active Treatment "Sveti Georgi" EAD

    Plovdiv, Bulgaria

  • Outpatient clinic for individual practice for specialized outpatient medical care in allergology-Doctor Thalat Sally Cholak EOOD

    Razgrad, Bulgaria

  • Medical Center Iskar EOOD Office of Clinical Allergology

    Sofia, Bulgaria

  • Medical Center "SYNEXUS SOFIA", EOOD

    Sofia, Bulgaria

  • Vahlberg & Pild Clinic

    Tallinn, Estonia

  • Healthy Future

    Tbilisi, Georgia

  • Center of Allergy and Immunology

    Tbilisi, Georgia

  • Multiprofile Clinic Consilium Medulla

    Tbilisi, Georgia

  • Charite - Institute of Allergology IFA Campus Benjamin Franklin

    Berlin, Germany

  • Universitätsklinikum Heidelberg - Dermatologie

    Heidelberg, Germany

  • LMU Klinikum - Klinik und Poliklinik für Dermatologie und Allergologie DASZ-Dermato-Allergologisches Studien Zentrum

    München, Bavaria, Germany

  • Universitaetsklinikum Giessen u. Marburg GmbH

    Marburg, Hesse, Germany

  • Hannover Medical University

    Hanover, Lower Saxony, Germany

  • Klinikum Oldenburg gGmbH - Klinik f. Dermatologie u. Allergologie

    Oldenburg, Lower Saxony, Germany

  • Universitätsklinikum Düsseldorf - Dermatologie

    Düsseldorf, North Rhine-Westphalia, Germany

  • Universitätsklinikum Münster Klinik u. Poliklinik f. Dermatologie

    Münster, North Rhine-Westphalia, Germany

  • Universitätsklinikum Dresden

    Dresden, Saxony, Germany

  • Universitätsklinikum Schleswig-Holstein - Zentrum für entzündliche Hauterkrankunge

    Kiel, Schleswig-Holstein, Germany

  • Semmelweis Egyetem, ÁOK, Bőr-, Nemikórtani és Bőronkológiai Klinika

    Budapest, Hungary

  • Debreceni Egyetem, ÁOK és KK, Bőrgyógyászati Tanszék és Bőrgyógyászati Klinika

    Debrecen, Hungary

  • Allergo-Derm Bakos Kft. Bőrgyógyászati Magánrendelő

    Szolnok, Hungary

  • Óbudai Egészségügyi Centrum Kft.

    Zalaegerszeg, Hungary

  • Centrum Medyczne Plejady

    Krakow, Poland

  • Malopolskie Centrum Alergologii

    Krakow, Poland

  • Uniwersytecki Szpital Kliniczny nr 1 w Lodzi

    Lodz, Poland

  • Luxderm Specjalistyczny Gabinet Dermatologiczny Prof. Doroty Krasowskie

    Lublin, Poland

Showing 40 of 56 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.